lt p gt AngioSoma, Inc., a Nevada corporation, is a clinical stage biotechnology company focused on improving the effectiveness of current standard of care treatments, especially related to endovascular interventions in the treatment of peripheral artery disease PAD . The Company is developing its lead product, a drug candidate called LiprostinTM for the treatment of peripheral artery disease, or PAD, which has completed FDA Phase I and three Phase II clinical trials. We are in discussions with several contract research organizations for completion of our FDA protocol for Phase III and submission of our new drug application for marketing in the US and its territories. lt /p gt
Quote | First Titan (OTCMKTS:SOAN)
Last: | $0.0683 |
---|---|
Change Percent: | 0.0% |
Open: | $0.064 |
Close: | $0.0683 |
High: | $0.074 |
Low: | $0.06 |
Volume: | 6,260,473 |
Last Trade Date Time: | 07/05/2021 04:41:55 am |
News | First Titan (OTCMKTS:SOAN)
FINRA Approval for the AngioSoma name change is effective immediately. RICHLAND, WA / ACCESSWIRE / July 6, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) is now officially GlobeStar Therapeutics Corporation (OTC PINK:GSTC). This announcement is effective immediately and the market effective ...
Srinivasan's medical management experience, leadership positions, and advisory experience will add additional depth to the AngioSoma team. RICHLAND, WA / ACCESSWIRE / July 1, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Kaushik Srinivasan, CEO, Radiant Health, to the Advisory Board....
Message Board Posts | First Titan (OTCMKTS:SOAN)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
First Titan Company Name:
SOAN Stock Symbol:
OTCMKTS Market:
FINRA Approval for the AngioSoma name change is effective immediately. RICHLAND, WA / ACCESSWIRE / July 6, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) is now officially GlobeStar Therapeutics Corporation (OTC PINK:GSTC). This announcement is effective immediately and the market effective ...
Srinivasan's medical management experience, leadership positions, and advisory experience will add additional depth to the AngioSoma team. RICHLAND, WA / ACCESSWIRE / July 1, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Kaushik Srinivasan, CEO, Radiant Health, to the Advisory Board....
Dr. Lewis's medical experience and research background will play a significant role in AngioSoma. RICHLAND, WA / ACCESSWIRE / June 22, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Dr. Michael Lewis, MD, to the Medical Advisory Board. Dr. Lewis's experience in frontier sciences, pati...